Latest News - GE HealthCare Technologies

Top Corporates Hub

GE HealthCare Technologies

GEHC | NASDAQ | United States
500
+21
Rank
$35.26B
Market Cap
$19.67B
+$ 0.12B
+0.61%
Revenue
$3.09B
+$ 0.19B
+6.55%
Earnings
53K
+2K
+3.92%
Employees
Medtronic Neurosurgery Imaging Tie Up May Influence Digital Surgery Valuation

10.04.2026 15:08

GE HealthCare and Medtronic (NYSE:MDT) have launched a digital integration between the bkActiv intraoperative ultrasound and the Stealth AXiS surgical navigation system. The integration is now commercially available and is designed to support cranial neurosurgery with real-time imaging during procedures. This launch connects Medtronic's navigation and robotics platforms with GE HealthCare's imaging into a unified workflow in the operating room. For you as an investor, this update sits at...

Read More

GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging

10.04.2026 14:28

GE HealthCare teams with Medtronic to integrate real-time imaging in cranial surgery, aiming to enhance precision, workflows and clinician decision-making.

Read More

Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now

08.04.2026 14:38

INSP gains from Inspire V gains traction, strong demand and margin gains boost results, but reimbursement shifts and WISeR rollout weigh on near-term outlook.

Read More

Artivion Secures FDA Approval for NEXUS Aortic Arch System

08.04.2026 14:33

AORT jumps after FDA approves NEXUS Aortic Arch System, unlocking a potential Endospan acquisition and advancing minimally invasive care for high-risk patients.

Read More

GE HealthCare And Stanford Deepen AI Imaging Ties For Future Products

08.04.2026 06:11

GE HealthCare Technologies (NasdaqGS:GEHC) is expanding its collaboration with Stanford Radiology to establish a Center of Excellence focused on imaging and advanced AI research. The Center of Excellence will target multiple modalities, including MR, CT, molecular imaging, and pharmaceutical diagnostics. The renewed partnership formalizes a broader institutional effort to help move imaging technologies and next generation diagnostics from research to clinical use. GE HealthCare...

Read More

PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch

07.04.2026 15:01

PAVmed taps industry veteran Joseph Virgilio to lead its device portfolio relaunch to boost growth, commercialization and long-term shareholder value.

Read More

GE HealthCare's Quarterly Earnings Preview: What You Need to Know

07.04.2026 11:41

GE HealthCare is set to release its first-quarter results later this month, with analysts forecasting a single-digit rise in earnings.

Read More

GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CT System

05.04.2026 18:31

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best large cap value stocks to buy according to analysts. On March 23, GE HealthCare received FDA 510(k) clearance for its Photonova Spectra, which is a next-gen photon-counting computed tomography system. This regulatory milestone follows the system’s debut at the 2025 Radiological Society of North America […]

Read More

GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know

03.04.2026 00:16

A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and patented drugs.

Read More

GEHC or ABT: Which Is the Better Value Stock Right Now?

01.04.2026 15:40

GEHC vs. ABT: Which Stock Is the Better Value Option?

Read More

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

01.04.2026 15:40

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the outlook.

Read More

A Look At GE HealthCare Technologies (GEHC) Valuation After Photonova Spectra FDA Clearance And Cardiology Updates

01.04.2026 14:11

GE HealthCare Technologies (GEHC) is back in focus after securing U.S. FDA 510(k) clearance for its Photonova Spectra photon-counting CT system, spotlighting cardiology focused imaging advances alongside new product integrations and collaborations. See our latest analysis for GE HealthCare Technologies. Despite the recent cardiology product news and the latest ex dividend announcement, GE HealthCare’s momentum has cooled. The company has seen a 30 day share price return decline of 11.2% and a...

Read More

How Investors Are Reacting To GEHC’s FDA-Cleared Photon-Counting CT And New Cardiology Platform Push

01.04.2026 13:14

In late March 2026, GE HealthCare Technologies received U.S. FDA 510(k) clearance for its Photonova Spectra photon-counting CT system and showcased a suite of cardiology innovations spanning CT, ultrasound, ECG fleet management, and interventional imaging collaborations to support precision care across the full cardiology pathway. The combination of AI-enabled photon-counting CT, Deep Silicon detector technology, cloud-connected device management, and new interventional partnerships...

Read More

Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term

31.03.2026 13:40

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More

Radiation Oncology Treatment Planning Software Market Report 2026: Siemens Healthineers, Koninklijke Philips, and GE Healthcare Technologies Lead

31.03.2026 12:16

Growth is driven by rising cancer incidence, advanced imaging technologies, and the expansion of oncology centers, with strong potential in Asia-Pacific and focus on personalized treatment Radiation Oncology Treatment Planning Software Market Radiation Oncology Treatment Planning Software Market Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Radiation Oncology Treatment Planning Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis

Read More

How The GE HealthCare Technologies (GEHC) Narrative Is Shifting With New MedTech Clears And Cautious Targets

29.03.2026 07:05

GE HealthCare Technologies’ blended fair value estimate has shifted only slightly, from about US$93.05 to US$93.47 per share, signaling a very small adjustment to where analysts see the stock’s price target landing. That kind of incremental move aligns with street research that combines optimism about MedTech fundamentals and new product clearances with some caution around sector volatility and policy risk. As you read on, you will see how these small target tweaks, plus the latest commentary...

Read More

GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe

26.03.2026 12:30

CHICAGO, March 26, 2026--GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI

Read More

GE HealthCare Announces Role In New COMPASS Consortium

26.03.2026 08:40

GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of

Read More

GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations

25.03.2026 13:00

CHICAGO, March 25, 2026--At ACC.26, GE HealthCare (Nasdaq: GEHC) will showcase some of its boldest ideas yet that support clinicians across the cardiology care pathway - from diagnosis to treatment to procedural guidance and monitoring. Its latest cardiology innovations, featuring advancements within diagnostic cardiology, CT, image guiding solutions, ultrasound, cloud, and software solutions, are helping clinicians deliver critical precision care throughout the patient journey.

Read More

GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance

23.03.2026 13:59

CHICAGO, March 23, 2026--GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra,i an innovative photon‑counting computed tomography (PCCT) solution powered by the company’s novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. With wide coverage and the combination of ultra-high definition (UHD) spatial and spectral imaging, Photonova Spectr

Read More